Physician profile
David E Fumo
NPI 1114314556
$6,063.69
in general payments reported to CMS, 2019-2025
26 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.96 · 2021: $47.14 · 2022: $471 · 2023: $267 · 2024: $4,683 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,607 · Travel and Lodging: $1,512 · Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,606.87 |
| Travel and Lodging | $1,512.05 |
| Food and Beverage | $1,336.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,803.53 | 2023-2025 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $714.23 | 2024 | Aquabeam System |
| Medtronic, INC. | $401.86 | 2022 | |
| Abbvie INC. | $168.44 | 2023-2025 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $116.95 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $113.96 | 2020-2023 | Speedicath |
| Convatec INC. | $65.82 | 2023-2025 | |
| Antares Pharma, INC. | $64.74 | 2022-2025 | Xyosted |
| Myovant Sciences INC. | $59.89 | 2021-2022 | |
| Teleflex LLC | $47.23 | 2022-2024 | Urolift |
| Tolmar, INC. | $41.88 | 2025 | Jatenzo, Eligard |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Astellas Pharma US INC | $30.70 | 2022-2023 | Myrbetriq |
| Halozyme INC | $28.79 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $28.40 | 2023-2024 | |
| Janssen Biotech, INC. | $26.43 | 2025 | Erleada |
| Pacira Pharmaceuticals Incorporated | $24.16 | 2025 | Exparel |
| C. R. Bard, INC. & Subsidiaries | $24.12 | 2024 | Personal Catheter Intermittent Catheter |
| Urogen Pharma, INC. | $23.57 | 2025 | |
| Axonics, INC. | $23.44 | 2023 | Axonics |
| Progenics Pharmaceuticals, INC. | $21.00 | 2023 | Pylarify |
| Endo USA, INC. | $20.21 | 2025 | Xiaflex |
| Urovant Sciences INC | $14.55 | 2022 | |
| Amgen INC. | $13.75 | 2024 | Prolia |
| Laborie Medical Technologies Corp. | $13.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fumo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.